Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5955851 | Chest | 2013 | 9 Pages |
Abstract
6MWD and BNP values at baseline or week 12 identified a population with an elevated risk of death at 2 years. A repeat assessment of 6MWD or BNP after 12 weeks of ambrisentan therapy did not provide additional prognostic information beyond that obtained from baseline values.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jason S. MD, Christiana MS, Ronald J. MD, FCCP, Christopher PhD, Horst MD, FCCP, Darrin MS, Hunter MD, Steven M. MD, FCCP,